References for Hepatitis C: A Focus on Dietary Supplements
- Azzam HS, Goertz C, Fritts M, et al. Natural products and chronic hepatitis C virus. Liver International. 2007;27(1):17–25.
- Dhiman RK, Chawla YK. Herbal medicines for liver diseases. Digestive Diseases and Sciences. 2005;50(10):1807–1812.
- Feld JJ, Modi AA, El-Diwani R, et al. S-adenosyl-methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonresponders. Gastroenterology. 2011;140(3):830–839.
- Filipowicz M, Bernsmeier C, Terracciano L, et al. S-adenosyl-methionine and betaine improve early virological response in chronic hepatitis C patients with previous nonresponse. PLoS ONE. 2010;5(11):e15492.
- Fried MW, Navarro VJ, Afdhal N, et al. Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial. JAMA. 2012;308(3):274–282.
- Ghany MG, Strader DB, Thomas DL, et al. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology. 2009;49(4):1335–1374.
- Grüngreiff K, Reinhold D. Zinc: a complementary factor in the treatment of chronic hepatitis C? Molecular Medicine Reports. 2010;3(3):371–375.
- Gratz SW, Mykkanen H, El-Nezami HS. Probiotics and gut health: a special focus on liver diseases. World Journal of Gastroenterology. 2010;16(4):403–410.
- Hawke RL, Schrieber SJ, Soule TA, et al. Silymarin ascending multiple oral dosing phase I study in noncirrhotic patients with chronic hepatitis C. Journal of Clinical Pharmacology. 2010;50(4):434–449.
- Hempel S, Newberry S, Ruelaz A, et al. Safety of Probiotics to Reduce Risk and Prevent or Treat Disease. Evidence Report/Technology Assessment no. 200. Agency for Healthcare Research and Quality Web site. Accessed at www.ahrq.gov/research/findings/evidence-based-reports/er200-abstract.html#Report on April 3, 2013.
- Kaito M, Iwasa M, Fujita N, et al. Effect of lactoferrin in patients with chronic hepatitis C: combination therapy with interferon and ribavirin. Journal of Gastroenterology and Hepatology. 2007;22(11):1894–1897.
- Kligler B, Cohrssen A. Probiotics. American Family Physician. 2008;78(9):1073–1078.
- Prasad AS. Zinc: role in immunity, oxidative stress and chronic inflammation. Current Opinion in Clinical Nutrition and Metabolic Care. 2009;12(6):646–652.
- Raymond RS, Fallon MB, Abrams GA. Oral thymic extract for chronic hepatitis C in patients previously treated with interferon. A randomized, double-blind, placebo-controlled trial. Annals of Internal Medicine. 1998;129(10):797–800.
- Richmond JA, Bailey DE, Patel K, et al. The use of complementary and alternative medicine by patients with chronic hepatitis C. Complementary Therapies in Clinical Practice. 2010;16(3):124–131.
- Seeff LB, Curto TM, Szabo G, et al. Herbal product use by persons enrolled in the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial. Hepatology. 2008;47(2):605–612.
- Sethi T. Probiotics in pediatric care. Explore. 2009;5(4):245–249.
- Takagi H, Nagamine T, Abe T, et al. Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C. Journal of Viral Hepatitis. 2001;8(5):367–371.
